• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[原发性血小板增多症作为年轻女性头痛的一个病因]

[Essential thrombocythemia as a cause of headache in young woman].

作者信息

Bieniaszewska M, Balon J, Hellmann A

机构信息

Kliniki Hematologii Instytutu Chorób Wewnetrznych AM w Gdańsku.

出版信息

Pol Merkur Lekarski. 2000 Jul;8(49):479-80.

PMID:11070720
Abstract

A case of severe headache in a young woman is described. The headache was not associated with additional neurological findings. In peripheral blood extremely high count of platelets was found. Additional examinations supported the diagnosis of essential thrombocythemia (ET). As a first line treatment thrombocytapheresis was performed. The introduced hydroxyurea treatment was complicated with dysmenorrhea and neutropenia. It was the reason to the use anagrelide--a new antiplatelet drug--in the therapy of ET. The treatment with anagrelide was free of previously mentioned complications. After one year of observation the platelet count was still effectively reduced.

摘要

描述了一名年轻女性严重头痛的病例。该头痛与其他神经系统检查结果无关。在外周血中发现血小板计数极高。进一步检查支持原发性血小板增多症(ET)的诊断。作为一线治疗,进行了血小板单采术。引入的羟基脲治疗出现痛经和中性粒细胞减少的并发症。这就是在ET治疗中使用阿那格雷——一种新型抗血小板药物——的原因。阿那格雷治疗未出现上述并发症。经过一年的观察,血小板计数仍有效降低。

相似文献

1
[Essential thrombocythemia as a cause of headache in young woman].[原发性血小板增多症作为年轻女性头痛的一个病因]
Pol Merkur Lekarski. 2000 Jul;8(49):479-80.
2
Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile.阿那格雷治疗骨髓增殖性疾病血小板增多症:一项评估疗效和不良事件特征的前瞻性研究。
Cancer. 2004 Nov 15;101(10):2239-46. doi: 10.1002/cncr.20646.
3
Therapeutic thrombocytapheresis for extreme thrombocytosis after chemotherapy in essential thrombocytosis.原发性血小板增多症化疗后极度过多血小板血症的治疗性血小板单采术
J Clin Apher. 2019 Aug;34(4):503-506. doi: 10.1002/jca.21683. Epub 2019 Jan 9.
4
Primary thrombocythemia: a current perspective.
Stem Cells. 1995 Jul;13(4):355-9. doi: 10.1002/stem.5530130406.
5
The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.血小板单采术在骨髓增殖性肿瘤高血小板血症当代管理中的作用:基于病例的综述。
Leuk Res. 2017 Jul;58:14-22. doi: 10.1016/j.leukres.2017.03.008. Epub 2017 Mar 22.
6
Long-term management of thrombocytosis in essential thrombocythaemia.原发性血小板增多症中血小板增多的长期管理。
Ann Hematol. 2009 Jan;88(1):1-10. doi: 10.1007/s00277-008-0531-7. Epub 2008 Jul 16.
7
Cost-effectiveness considerations in the treatment of essential thrombocythemia.原发性血小板增多症治疗中的成本效益考量
Semin Oncol. 2002 Jun;29(3 Suppl 10):28-32. doi: 10.1053/sonc.2002.33758.
8
[Appearance of leg ulcers associated with intake of anagrelide].
Dtsch Med Wochenschr. 2007 Feb 16;132(7):319-21. doi: 10.1055/s-2007-959325.
9
Anagrelide: new drug. Essential thrombocythaemia: further evaluation needed for this last-resort treatment.阿那格雷:新药。原发性血小板增多症:这种最后手段的治疗方法需要进一步评估。
Prescrire Int. 2006 Jun;15(83):83-6.
10
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders.阿那格雷对血小板增多症和骨髓增殖性疾病患者血小板计数及功能的影响。
Haematologica. 1992 Jan-Feb;77(1):40-3.